Btc Capital Management, Inc. Crispr Therapeutics Ag Transaction History

Btc Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$43.23 - $73.83 $138,508 - $236,551	-3,204 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$53.19 - $79.24 $23,244 - $34,627	437 Added 15.79%	3,204 $200,000
Q4 2021 Feb 09, 2022	BUY	$70.09 - $111.29 $193,939 - $307,939	2,767 New	2,767 $210,000
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $158,247 - $224,935	-1,436 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$100.84 - $161.89 $40,436 - $64,917	-401 Reduced 21.83%	1,436 $233,000
Q1 2021 May 04, 2021	SELL	$110.72 - $210.04 $27,126 - $51,459	-245 Reduced 11.77%	1,837 $224,000
Q4 2020 Jan 28, 2021	BUY	$79.67 - $173.23 $165,872 - $360,664	2,082 New	2,082 $317,000
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $124,674 - $232,234	-5,485 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $51,534 - $76,355	1,162 Added 26.88%	5,485 $246,000
Q2 2018 Aug 15, 2018	BUY	$42.62 - $73.59 $184,246 - $318,129	4,323 New	4,323 $258,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Btc Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Btc Capital Management, Inc. with notifications on news.